Biotech FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE June 15, 2024
Biotech Global Cell and Gene Therapy Market Expected to Grow at 26.4% CAGR, Reaching $23.3 Billion by 2028 June 14, 2024
Biotech Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee Cartilage Implant at the 9th Joint Preservation Congress in Warsaw, Poland on June 14-15, 2024 June 14, 2024
Biotech Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary June 14, 2024
Biotech Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy June 13, 2024
Biotech Xeltis receives IDE approval from FDA for initiation of US pivotal trial for aXess™, its restorative vascular access conduit June 13, 2024
Biotech NSG BioLabs and Eppendorf Group Sign Partnership to Support Biotech Companies in Singapore June 13, 2024
Biotech Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer June 13, 2024
Biotech Alida Biosciences Announces Series A Funding and Early Access Launch of Innovative Products for Epitranscriptomic Research June 12, 2024